To identify the differences in oncological outcomes for patients with different pT3a renal tumor invasion patterns and pathological features.
The protocol of this study was registered on PROSPERO (CRD42021234475).
To identify the differences in oncological outcomes for patients with different pT3a renal tumor invasion patterns and pathological features.
The protocol of this study was registered on PROSPERO (CRD42021234475).